{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:32:18Z","timestamp":1790353938900,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.antiviral.2013.02.013","type":"journal-article","created":{"date-parts":[[2013,2,28]],"date-time":"2013-02-28T21:05:54Z","timestamp":1362085554000},"page":"297-304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"title":["Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002\u20132012 shows need for continued monitoring"],"prefix":"10.1016","volume":"98","author":[{"given":"Elena A.","family":"Govorkova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Baranovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Seiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianling","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Burnham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malik","family":"Peiris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Webby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2013.02.013_b0005","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1086\/656316","article-title":"Effectiveness of antiviral treatment in human influenza H5N1 infections: analysis from a global patient registry","volume":"202","author":"Adisasmito","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.02.013_b0010","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.antiviral.2008.06.008","article-title":"Adamantane resistance in influenza A(H1) viruses increased in 2007 in South East Asia but decreased in Australia and some other countries","volume":"80","author":"Barr","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.02.013_b0015","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1099\/vir.0.017459-0","article-title":"Emergence of H5N1 avian influenza viruses with reduced sensitivity to neuraminidase inhibitors and novel reassortants in Lao PDR","volume":"91","author":"Boltz","year":"2010","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2013.02.013_b0020","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/jama.295.8.joc60020","article-title":"Adamantane resistance among influenza A viruses isolated early during the 2005\u20132006 influenza season in the United States","volume":"295","author":"Bright","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2013.02.013_b0025","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/infdis\/jis509","article-title":"Determinants of antiviral effectiveness in influenza virus A subtype H5N1","volume":"206","author":"Chan","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.02.013_b0030","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1086\/504723","article-title":"Distribution of amantadine-resistant H5N1 avian influenza variants in Asia","volume":"193","author":"Cheung","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.02.013_b0035","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1086\/518936","article-title":"Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide","volume":"196","author":"Deyde","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.02.013_b0040","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/jama.2009.294","article-title":"Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States","volume":"301","author":"Dharan","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2013.02.013_b0045","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jiph.2009.04.004","article-title":"Oseltamivir resistance mutation N294S in human influenza A(H5N1) virus in Egypt","volume":"2","author":"Earhart","year":"2009","journal-title":"J. Infect. Pub. Health"},{"key":"10.1016\/j.antiviral.2013.02.013_b0050","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1128\/AAC.01667-08","article-title":"Susceptibility of highly pathogenic H5N1 influenza viruses to the neuraminidase inhibitor oseltamivir differs in vitro and in a mouse model","volume":"53","author":"Govorkova","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.02.013_b0055","doi-asserted-by":"crossref","first-page":"8042","DOI":"10.1128\/JVI.00689-10","article-title":"Competitive fitness of oseltamivir-sensitive and -resistant highly pathogenic H5N1 influenza viruses in a ferret model","volume":"84","author":"Govorkova","year":"2010","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.antiviral.2013.02.013_b0060","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.3851\/IMP1678","article-title":"Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro","volume":"15","author":"Gubareva","year":"2010","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2013.02.013_b0065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/jac\/18.Supplement_B.19","article-title":"Molecular basis of resistance of influenza A viruses to amantadine","volume":"18","author":"Hay","year":"1986","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2013.02.013_b0070","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.antiviral.2007.08.007","article-title":"Amantadine-resistance among H5N1 avian influenza viruses isolated in Northern China","volume":"77","author":"He","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.02.013_b0075","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.meegid.2008.10.006","article-title":"Evolution of drug resistance in multiple distinct lineages of H5N1 avian influenza","volume":"9","author":"Hill","year":"2009","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.antiviral.2013.02.013_b0080","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.antiviral.2006.10.004","article-title":"Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes","volume":"73","author":"Hurt","year":"2007","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.02.013_b0085","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/AAC.00334-09","article-title":"In vitro generation of neuraminidase inhibitor resistance in A(H5N1) influenza viruses","volume":"53","author":"Hurt","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.02.013_b0090","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/135965350701200302","article-title":"Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice","volume":"12","author":"Ilyushina","year":"2007","journal-title":"Antiviral Ther."},{"issue":"6 (5)","key":"10.1016\/j.antiviral.2013.02.013_b0095","doi-asserted-by":"crossref","first-page":"e1000933","DOI":"10.1371\/journal.ppat.1000933","article-title":"Effect of neuraminidase inhibitor\u2013resistant mutations on pathogenicity of clade 2.2 A\/Turkey\/15\/06 (H5N1) influenza virus in ferrets","volume":"27","author":"Ilyushina","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2013.02.013_b0100","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.coviro.2011.09.002","article-title":"Antivirals and resistance. Influenza virus","volume":"1","author":"Ison","year":"2011","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.antiviral.2013.02.013_b0105","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa054512","article-title":"Oseltamivir resistance during treatment of influenza A (H5N1) infection","volume":"353","author":"de Jong","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2013.02.013_b0110","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.3201\/eid1712.110683","article-title":"Continuing threat of influenza (H5N1) virus circulation in Egypt","volume":"17","author":"Kayali","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.02.013_b0115","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1128\/JVI.00047-11","article-title":"Effect of an asparagine-to-serine mutation at position 294 in neuraminidase on the pathogenicity of highly pathogenic H5N1 influenza A virus","volume":"85","author":"Kiso","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.02.013_b0120","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nature02746","article-title":"Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia","volume":"430","author":"Li","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2013.02.013_b0125","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/4371108a","article-title":"Avian flu: isolation of drug-resistant H5N1 virus","volume":"437","author":"Le","year":"2005","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.antiviral.2013.02.013_b0130","doi-asserted-by":"crossref","first-page":"e3339","DOI":"10.1371\/journal.pone.0003339","article-title":"Influenza A H5N1 clade 2.3.4 virus with a different antiviral susceptibility profile replaced clade 1 in humans in Northern Vietnam","volume":"3","author":"Le","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2013.02.013_b0135","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1745-6150-4-18","article-title":"Mapping the sequence mutations of the 2009 H1N1 influenza A virus neuraminidase relative to drug and antibody binding sites","volume":"4","author":"Maurer-Stroh","year":"2009","journal-title":"Biol. Direct"},{"key":"10.1016\/j.antiviral.2013.02.013_b0140","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.3201\/eid1810.120357","article-title":"Spread of influenza virus a (h5n1) clade 2.3.2.1 to Bulgaria in Common Buzzards","volume":"18","author":"Marinova-Petkova","year":"2012","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.02.013_b0145","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/rmv.372","article-title":"Natural and synthetic sialic acid-containing inhibitors of influenza virus receptor binding","volume":"13","author":"Matrosovich","year":"2003","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2013.02.013_b0150","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.3201\/eid1309.07-0164","article-title":"Reduced sensitivity of influenza A (H5N1) viruses","volume":"9","author":"McKimm-Breschkin","year":"2007","journal-title":"Emerg. Infect. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2013.02.013_b0155","first-page":"25","article-title":"Influenza neuraminidase inhibitors: antiviral action and mechanism of resistance","volume":"7","author":"McKimm-Breshkin","year":"2012","journal-title":"Influenza Other Resp. Viruses"},{"key":"10.1016\/j.antiviral.2013.02.013_b0160","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1099\/vir.0.2008\/004259-0","article-title":"Co-circulation of two sublineages of HPAI H5N1 virus in the Kingdom of Saudi Arabia with unique molecular signatures suggesting separate introductions into the commercial poultry and falconry sectors","volume":"89","author":"Monne","year":"2008","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2013.02.013_b0165","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1086\/656439","article-title":"Recovery of a multidrug-resistant strain of pandemic influenza A 2009 (H1N1) virus carrying a dual H275Y\/I223R mutation from a child after prolonged treatment with oseltamivir","volume":"51","author":"Nguyen","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.02.013_b0170","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0092-8674(92)90452-I","article-title":"Influenza virus M2 protein has ion channel activity","volume":"69","author":"Pinto","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2013.02.013_b0175","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1055\/s-0031-1283281","article-title":"Influenza drug resistance","volume":"32","author":"Pizzorno","year":"2011","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.antiviral.2013.02.013_b0180","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0003-2697(79)90362-2","article-title":"Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate","volume":"94","author":"Potier","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.antiviral.2013.02.013_b0185","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1016\/j.vaccine.2010.03.068","article-title":"Safety and immunogenicity of prepandemic H5N1 influenza vaccines: a systematic review of the literature","volume":"28","author":"Prieto-Lara","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2013.02.013_b0190","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1128\/AAC.00645-06","article-title":"Natural variation can significantly alter sensitivity to oseltamivir of influenza A (H5N1) viruses","volume":"50","author":"Rameix-Welti","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.02.013_b0200","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1473-3099(06)70684-3","article-title":"WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus","volume":"7","author":"Schunemann","year":"2007","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.02.013_b0205","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1128\/AAC.01739-09","article-title":"In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses","volume":"54","author":"Sleeman","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.antiviral.2013.02.013_b0210","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1371\/journal.ppat.0030040","article-title":"H5N1 viruses and vaccines","volume":"3","author":"Subbarao","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2013.02.013_b0215","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1093\/molbev\/msr121","article-title":"MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods","volume":"28","author":"Tamura","year":"2011","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.antiviral.2013.02.013_b0220","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11262-010-0534-z","article-title":"Emergence of amantadine-resistant avian influenza H5N1 virus in India","volume":"42","author":"Tosh","year":"2011","journal-title":"Virus Genes"},{"key":"10.1016\/j.antiviral.2013.02.013_b0225","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1056\/NEJMc1003749","article-title":"Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus","volume":"363","author":"van der Vries","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.antiviral.2013.02.013_b0230","doi-asserted-by":"crossref","first-page":"e1697","DOI":"10.1371\/journal.pone.0001697","article-title":"Influenza A H5N1 immigration is filtered out at some international borders","volume":"3","author":"Wallace","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2013.02.013_b0235","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1001\/jama.2009.324","article-title":"The evolution of influenza resistance and treatment","volume":"301","author":"Weinstock","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2013.02.013_b0240","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMra0707279","article-title":"Update on avian influenza A (H5N1) virus infection in humans","volume":"358","author":"Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A (H5N1) Virus. Update on avian influenza A (H5N1) virus infection in humans","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2013.02.013_b0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1750-2659.2011.00298.x","article-title":"Continued evolution of highly pathogenic avian influenza A (H5N1): updated nomenclature","volume":"6","author":"WHO\/OIE\/FAO H5N1 Evolution Working Group.","year":"2012","journal-title":"Influenza and Other Respiratory Viruses"},{"key":"10.1016\/j.antiviral.2013.02.013_b0250","unstructured":"World Health Organization, 2007. Clinical management of human infection with avian influenza A (H5N1) virus. Updated advice 15 August 2007. Available: <http:\/\/www.who.int\/csr\/disease\/avian_influenza\/guidelines\/ClinicalManagement07.pdf> (accessed October 2012)."},{"key":"10.1016\/j.antiviral.2013.02.013_b0255","unstructured":"World Health Organization. 2012. Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO, 2003-2012. <http:\/\/www.who.int\/influenza\/human_animal_interface\/EN_GIP_20120810CumulativeNumberH5N1cases.pdf> (published 10 10 12)."},{"key":"10.1016\/j.antiviral.2013.02.013_b0260","doi-asserted-by":"crossref","first-page":"12418","DOI":"10.1128\/JVI.01067-07","article-title":"Neuraminidase inhibitor\u2013resistant recombinant A\/Vietnam\/1203\/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo","volume":"81","author":"Yen","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.02.013_b0265","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1128\/JCM.01532-09","article-title":"Genetic makeup of amantadine-resistant and oseltamivir-resistant human influenza A\/H1N1 viruses","volume":"48","author":"Zaraket","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2013.02.013_b0270","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1128\/JCM.00535-11","article-title":"Adamantane- and oseltamivir-resistant seasonal A (H1N1) and pandemic A (H1N1) 2009 influenza viruses in Guangdong, China, during 2008 and 2009","volume":"49","author":"Zhou","year":"2011","journal-title":"J. Clin. Microbiol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213000508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213000508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T20:33:34Z","timestamp":1688070814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354213000508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0166354213000508"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.02.013","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002\u20132012 shows need for continued monitoring","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}